You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Swedish node of the Nordic EMBL Partnership for Molecular Medicine, MIMS (Molecular Infection Medicine Sweden) has announced that that Dr. Oliver Billker from the Wellcome Sanger Institute, Cambridge, UK, has been recruited as the institute's future director. Oliver Billker is an expert in mAlready a subscriber Login You have read…
Radiation oncology firm Elekta said it has named Niklas Savander as its next president and CEO, effective May 1, 2014. Savander succeeds Tomas Puusepp, who will remain with the firm after May 1 as a working member of its board of directors, the company said. Savander has held senior management…
Johan Harmenberg has reached retirement age and as the company continues to expand its activities he has decided to step down as CMO but continue to work as a member of the company's medical team. Klaas Bakker has been appointed as the new Chief Medical Officer (CMO) for Oncopeptides, starting…
Anna-Lena Engwall has been appointed head of AstraZeneca's Nordic-Baltics marketing company and she started her new position February 6 2020. Anna Lena Engwall has long experience from the pharma and biotech industry and she has held a number of different managing positions at companies like NovaAlready a subscriber Login You…
